Queen Elizabeth II Health Sciences Centre

Hospital


Location: Halifax, Canada (CA) CA

ISNI: 000000040407789X

ROR: https://ror.org/025qrzc85

Show on Map:

Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study (2020) Dimopoulos MA, Lonial S, White D, Moreau P, Weisel K, San-Miguel J, Shpilberg O, et al. Journal article Intraductal carcinoma of the prostate is an aggressive form of invasive carcinoma and should be graded (2020) Samaratunga H, Delahunt B, Egevad L, Srigley JR, Billis A, Bostwick DG, Camparo P, et al. Journal article Intraductal carcinoma of the prostate is an aggressive form of invasive carcinoma and should be graded (2019) Samaratunga H, Delahunt B, Egevad L, Srigley JR, Billis A, Bostwick DG, Camparo P, et al. Journal article, Review article